Successfully completes single ascending dose phase of first clinical study in healthy subjects for a direct-to-lung, Thin Film Freezing (TFF) dry-powder formulation Invasive Pulmonary Aspergillosis is a severe fungal pulmonary disease with a mortality rate that can...
VANCOUVER, British Columbia, March 19, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company is pleased to announce that Novotech, a...
– Final Analysis Comparing 10 AllocetraTM-Treated Patients with 37 Matched Controls Showed Significant Positive Responses in State of Organ Failure, ICU Hospitalization and Mortality in a Highly Fragile and Extremely Difficult to Treat Population with Severe Sepsis –...
AGOURA HILLS, Calif., March 18, 2020 (GLOBE NEWSWIRE) — Mateon Therapeutics, Inc., (OTCQB:MATN) (“Mateon”) dedicated to development OT-101, a TGF-Beta antisense drug candidate, today provided an update on its rapid antiviral response program against...
·Last patient completes last visit in the six-month, placebo-controlled part of study ·18 patients have continued into open-label extension ·Top-line results from placebo-controlled part of study still expected in Q2 2020 Saniona (SANION.ST), a clinical stage...
Email
Text